Coherus Oncology, Inc. (CHRS) Net Margin
- 2026-06-30: Net Margin -144.20%.
- 2026-03-31: Net Margin -311.35%.
- 2025-12-31: Net Margin -295.29%.
- 2025-09-30: Net Margin -307.07%.
Complete source-backed net margin history.
- Available history
- 2012-12-31 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|
| 2026-06-30 | -144.20% |
|---|
| 2026-03-31 | -311.35% |
|---|
| 2025-12-31 | -295.29% |
|---|
| 2025-09-30 | -307.07% |
|---|
| 2025-06-30 | 2903.91% |
|---|
| 2025-03-31 | -744.43% |
|---|
| 2024-12-31 | -655.58% |
|---|
| 2024-09-30 | -177.64% |
|---|
| 2024-06-30 | -125.50% |
|---|
| 2024-03-31 | 4457.32% |
|---|
| 2023-12-31 | -87.03% |
|---|
| 2023-09-30 | -53.16% |
|---|
| 2023-06-30 | -73.01% |
|---|
| 2023-03-31 | -233.47% |
|---|
| 2022-12-31 | -129.81% |
|---|
| 2022-09-30 | -190.76% |
|---|
| 2022-06-30 | -83.37% |
|---|
| 2022-03-31 | -159.83% |
|---|
| 2021-12-31 | -62.32% |
|---|
| 2021-09-30 | -46.70% |
|---|
| 2021-06-30 | -34.12% |
|---|
| 2021-03-31 | -208.28% |
|---|
| 2020-12-31 | 8.79% |
|---|
| 2020-09-30 | 24.60% |
|---|
| 2020-06-30 | 43.51% |
|---|
| 2020-03-31 | 30.62% |
|---|
| 2019-12-31 | 31.67% |
|---|
| 2019-09-30 | 42.12% |
|---|
| 2019-06-30 | 28.25% |
|---|
| 2019-03-31 | -53.92% |
|---|
| 2017-06-30 | -3952.57% |
|---|
| 2017-03-31 | -46445.96% |
|---|
| 2016-12-31 | -35477.10% |
|---|
| 2016-09-30 | 51.55% |
|---|
| 2016-06-30 | -497.35% |
|---|
| 2016-03-31 | -529.07% |
|---|
| 2015-06-30 | -856.54% |
|---|
| 2015-03-31 | -700.95% |
|---|
Annual Net Margin
| Date | Net Margin |
|---|
| 2025-12-31 | 398.43% |
|---|
| 2024-12-31 | 108.03% |
|---|
| 2023-12-31 | -92.48% |
|---|
| 2022-12-31 | -138.24% |
|---|
| 2021-12-31 | -87.92% |
|---|
| 2020-12-31 | 27.79% |
|---|
| 2019-12-31 | 25.23% |
|---|
| 2017-12-31 | -15306.56% |
|---|
| 2016-12-31 | -67.20% |
|---|
| 2015-12-31 | -743.18% |
|---|
| 2014-12-31 | -280.12% |
|---|
| 2013-12-31 | -1949.65% |
|---|
| 2012-12-31 | -1738.70% |
|---|